Filing Details
- Accession Number:
- 0001711968-26-000023
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2026-10-02 21:35:07
- Reporting Period:
- 2026-10-01
- Filing Date:
- 2026-10-02
- Accepted Time:
- 2026-10-02 21:35:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1711968 | Leonard Steven Chapman | C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753 | Ceo and President | No | No | No | No |
Transaction Summary
| Sold: | 1,273 shares | Avg. Price: $413.31 | Total Value: $526,143.63 |
| Number of Shares After Transactions: | 96,926 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2026-10-01 | 1,273 | $413.31 | 96,926 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023, as amended on December 2, 2024, and as further amended on March 5, 2026.